logo

For the Inventor, By the Inventor

Hanover, Germany

Peter W Thies

USPTO Granted Patents = 17

Average Co-Inventor Count = 2.2

ph-index = 3

Forward Citations = 37(Granted Patents)


Location History:

  • Hanover, DE (1979 - 1987)
  • Hannover, DE (1977 - 1990)

Company Filing History:

goldMedal14 out of 92 
 
Kali-chemie Pharma Gmbh
 patents
silverMedal2 out of 102 
 
Kali-chemie Aktiengesellschaft
 patents
bronzeMedal1 out of 1 
 
Kali-chemic Pharma Gmbh
 patent

Years Active: 1977-1990

Loading Chart...
17 patents (USPTO):Explore Patents
1. 4980487 - Novel valepotriate hydrin containing medicines (1990-12-25),
2. 4891384 - Valepotriate hydrin containing medicines used to treat uclers and (1990-01-02),
3. 4714709 - N-(2,10-dioxa-tricyclo-[5,3,1,0.sup.3,8 ]-undecane-5-yl)-tryptamine (1987-12-22),
4. 4526991 - 2,6-Dioxa-bicyclo-[2,2,2]-octane-7-yl-acetaldehydes (1985-07-02),
5. 4391819 - 2,9-Dioxa tricyclo [4,3,1,0.sup.3,7 ] decane compounds and process of (1983-07-05),
6. 4256642 - Pharmaceutically active 2,9-dioxatricyclo[4,3,1,0.sup.3,7 ] decanes (1981-03-17),
7. 4242341 - 2,9-Dioxatricyclo [4,3,1,0.sup.3,7 ] decane derivatives and (1980-12-30),
8. 4207331 - 2,9-Dioxatricyclo[4,3,1,0.sup.3,7 ]decane derivatives and pharmaceutical (1980-06-10),
9. 4205083 - Cyclopentapyrans (1980-05-27),
10. 4189437 - Pharmaceutically active 2,9-dioxatricyclo[4,3,1,0.sup.3,7 ]decanes (1980-02-19),
11. 4182889 - Process for preparing 10-methyl-2,9-dioxatricyclo[4,3,1,0.sup.3,7 ] (1980-01-08),
12. 4163055 - 2,9-Dioxatricyclo[4,3,1,0.sup.3,7 ] decane derivatives and (1979-07-31),
13. 4158061 - 2,9-Dioxatricyclo[4,3,1,0.sup.3,7 ] decane derivatives, processes for (1979-06-12),
14. 4141988 - 2,9-Dioxatricyclo[4,3,1,0.sup.3,7 ]decane derivatives, processes for (1979-02-27),
15. 4117148 - 2,9-Dioxatricyclo [4,3,1,0,3,7] decane derivatives, processes for their (1978-09-26),

Title: The Innovative Contributions of Peter W. Thies

Introduction

Peter W. Thies, an influential inventor based in Hanover, DE, has made significant strides in the field of pharmaceuticals. With a remarkable portfolio of 17 patents, his work primarily focuses on innovative compositions that enhance gastrointestinal health. His inventions stand at the intersection of scientific research and practical application, impacting the way certain disorders are treated.

Latest Patents

Among his latest contributions to the field are two pivotal patents regarding valepotriate hydrins, showcasing their efficacy in both prevention and treatment of gastrointestinal disorders. The first patent highlights the use of valepotriate hydrins in pharmaceutical compositions aimed at addressing various gastrointestinal issues. Similarly, the second patent elaborates on the application of these compounds in treating ulcers. Both patents reflect Thies' commitment to advancing medical science through innovative solutions.

Career Highlights

Throughout his career, Peter W. Thies has been associated with renowned companies such as Kali-Chemie Pharma GmbH and Kali-Chemie Aktiengesellschaft. His tenure in these organizations has not only contributed to his personal growth but also to the advancement of pharmaceutical innovations. Thies’ expertise in compound formulation and drug development has paved the way for new medical therapies that provide relief to numerous patients.

Collaborations

Collaboration has been a cornerstone of Thies' work, allowing him to gain insights and expertise from fellow innovators. Notable coworkers include Samuel David and Akiji Asai, with whom he has shared ideas and strategies in the pursuit of groundbreaking pharmaceutical advancements. These partnerships have played an essential role in furthering his research and innovations, leading to the successful patenting of novel medicinal compositions.

Conclusion

Peter W. Thies exemplifies the spirit of innovation in the pharmaceutical domain. With a strong foundation in research and development, his numerous patents underscore the importance of collaboration and creativity in tackling health challenges. As the field of medicine continues to evolve, Thies’ work remains a significant contribution to the advancement of patient care and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…